ABSTRACT
In the present study, nine compounds (1-9) were isolated from Colletotrichum gloeosporioides (an endophytic fungus from Uncaria rhynchophylla) which was cultured in wheat bran medium. Their structures were elucidated as 4-Epi-14-hydroxy-10, 23-dihydro-24, 25-dehydroaflavinine (1), 10, 23-Dihydro-24,25 -dehydro-21-oxoaflavinine (2), Ergosterol (3), Ergosterol peroxide (4), Mellein (5), 4, 5-dihydroblumenol A (6), Colletotrichine A (7), Cyclo(L-leucyl-L-leucyl) (8), and Brevianamide F (9) based on NMR spectral data, as well as comparing with previous literature data. This is the first report about the isolation of compounds 1-2, 6, and 8-9 from Colletotrichum genus. All compounds were tested for their phosphoinositide 3-kinase (PI3Kα) inhibitory activity. Compounds 8 and 9 showed potent PI3K α inhibitory activity with IC50 values of 38.1 and 4.8 µM, respectively, while the other compounds showed very weak activity at a concentration of 20 µg/mL.
Subject(s)
Colletotrichum/metabolism , Enzyme Inhibitors/chemistry , Host-Pathogen Interactions , Phosphoinositide-3 Kinase Inhibitors , Uncaria/enzymology , Uncaria/microbiology , Colletotrichum/chemistry , Endophytes/chemistry , Endophytes/metabolism , Enzyme Inhibitors/isolation & purification , Inhibitory Concentration 50 , Molecular Structure , Secondary MetabolismABSTRACT
One new compound, Colletotrichine A (1), was produced by the fungal Colletotrichum gloeosporioides GT-7. The structure was established by 1D and 2D NMR spectra. Monoamine oxidase (MAO) and acetylcholinesterase (AChE) inhibitory activity of 1 was also evaluated. Compound 1 showed AChE-inhibiting activity with IC50 value of 28 µg/mL.
Subject(s)
Cholinesterase Inhibitors/chemistry , Colletotrichum/chemistry , Monoamine Oxidase Inhibitors/chemistry , Sesquiterpenes/chemistry , Uncaria/microbiology , Cholinesterase Inhibitors/pharmacology , Endophytes/chemistry , Inhibitory Concentration 50 , Monoamine Oxidase Inhibitors/pharmacology , Sesquiterpenes/pharmacologyABSTRACT
This study is designed to serve as a reference for the establishment of health security systems for children’s critical diseases. Through analysis of the operation of Shanghai Children Hospital Care Aid (SCHCA), this study explored the financing model and management of a children’s critical disease healthcare system and analyzed the possibility of expanding this system to other areas. It is found that a premium as low as RMB 7 per capita per year under SCHCA can provide high-level security for children’s critical diseases. With the good experience in Shanghai and based on the current basic medical insurance system for urban residents and the new rural cooperative medical scheme (NRCMS), it is necessary and feasible to build a health security system for children’s critical diseases at the national level.
